General Information of the Compound
Compound ID
CP0864650
Compound Name
N-(3-(1H-imidazol-1-yl)propyl)-4-bromonaphthalene-1-sulfonamide
    Show/Hide
Structure
Formula
C16H16BrN3O2S
Molecular Weight
394.294
Canonical SMILES
O=S(=O)(NCCCn1ccnc1)c1ccc(Br)c2ccccc12
    Show/Hide
InChI
InChI=1S/C16H16BrN3O2S/c17-15-6-7-16(14-5-2-1-4-13(14)15)23(21,22)19-8-3-10-20-11-9-18-12-20/h1-2,4-7,9,11-12,19H,3,8,10H2
    Show/Hide
InChIKey
FAQDDEMPGLGMPA-UHFFFAOYSA-N
Physicochemical Property
logP
3.1674
Rotatable Bonds
6
Heavy Atom Count
23
Polar Areas
63.99
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
4
Complexity
23

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 16004585
ChEMBL ID
CHEMBL4279075
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00877, Inhibitor of nuclear factor kappa-B kinase subunit beta
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000025 HEK-293T Homo sapiens (Human)  1
1
IC50 = 54700 nM
   TI
   LI
   LO
   TS